07.09.10

Haupt Pharma at the ICSE - Contract manufacturing and development at the highest level confirmed by successful completion of an FDA audit

06.09.10

Flexible and fast blister line for packaging cytostatics and immunosuppressives

27.08.10

Hans-Christian Semmler has resigned from his position as Chief Executive Officer of Haupt Pharma AG

Sitemap

HomeOverviewCompanySitesAmaregBerlinBrackenheimBrackenheimBrackenheimLatinaLivronMaltaMünsterNew separate production area for sex hormone-containing solidsTorideUSAWolfratshausenWülfingLoxxessManagementExecutive BoardSitesSalesStrategyPhilosophyQuality PolicyHistorySponsoringDigital Art Museum [DAM]Pharmaceutical DevelopmentServicesClinical SuppliesContract ManufacturingSolid dosage formsLiquid and semi-solid dosage formsSterile dosage formsHormone PreparationsCytostatic AgentsPackagingNews201020092008200720062005JobsContact
IntroSitemapImprintData ProtectionTerms & ConditionsSBTSS
SitemapSitemap